Yang R, Sanghvi N T, Rescorla F J, Kopecky K K, Grosfeld J L
Department of Surgery, Indiana University School of Medicine, Indianapolis.
Eur Urol. 1993;23 Suppl 1:17-22. doi: 10.1159/000474674.
Recent animal studies have demonstrated the capacity of high-intensity focused ultrasound (HIFU) to extracorporeally ablate selective tissue targets in the liver without requiring surgical exposure of the liver or insertion of instruments into the liver. The potential value of HIFU as a noninvasive local treatment for human hepatic cancers has attracted considerable interest. This report reviews the current status of HIFU research and sets forth questions for future study.
最近的动物研究表明，高强度聚焦超声（HIFU）能够在不进行肝脏手术暴露或不将器械插入肝脏的情况下，在体外消融肝脏中的选择性组织靶点。HIFU作为一种治疗人类肝癌的非侵入性局部治疗方法的潜在价值已引起了相当大的关注。本报告回顾了HIFU研究的现状，并提出了未来研究的问题。
